Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common
Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Our common stock is quoted
on the OTCQB under the symbol “DUKR.” As of March 18, 2025, there were 154 holders of record of our common stock. This figure
includes an indeterminate number of stockholders who hold their shares in “street name.”
We have not declared any cash
dividends on our common stock, and do not intend to declare dividends in the foreseeable future. Management intends to use all available
funds for the development of our plan of operation.
On March 18, 2025, our board
of directors approved to increase the amount of shares of Common Stock available under the 2021 Plan from 4,800,000 to 9,000,000.
On March 18, 2025, our board
of directors approved the following grants pursuant to our 2021 Plan:
(i) 1,000,000 options to purchase
shares of Common Stock to Mr. Yossef Balucka, CEO, at an exercise price of $0.21 per share, and vest in three equal installment of 33%
at the end of each year. The options expire after six (6) years from the date of grant, and such other terms and conditions set forth
in our 2021 Plan.
(ii) 500,000 options to our
Common Stock to Mr. Vadim Maor, CTO, at an exercise price of $0.21 per share. The options have the following vesting schedule: 33% of
the options will vest after 12 months and the remaining portion will vest in eight equal installments over eight quarters. The options
expire after six (6) years from the date of grant, and such other terms and conditions set forth in our 2021 Plan.
(iii) 120,000 options to purchase
shares of Common Stock to Ms. Keren Gousman Golan, director. The options were granted at an exercise price of $0.21 per share and vest
in three equal installment of 33% at the end of each year. The options expire after six (6) years from the date of grant, and such other
terms and conditions set forth in our 2021 Plan.
(iv) 400,000 options to purchase
shares of Common Stock to Mrs. Alexandra Papaconstantinou, Managing Director of Duke Greece. The options were granted at an exercise price
of $0.21 per share and vest in three equal installments of 33% at the end of each year. The options expire after six (6) years from the
date of grant, and such other terms and conditions set forth in our 2021 Plan.
(v) 50,000 options to purchase
shares of Common Stock to Mr. Shlomo Zakai, CFO, at an exercise price of $0.21 per share, and vest in three equal installment of 33% at
the end of each year. The options expire after six (6) years from the date of grant, and such other terms and conditions set forth in
our 2021 Plan.
Item 6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the is authoritative for anything you rely on.